Search results

Selected filters:

Litigation
News

Article type

Topic

Sector

Regions

Year

415 results found for your search

Sort options
10 October 2019

Patent term adjustments in the US are readjusted, again

Two recent Federal Circuit decisions have shed further light on a highly litigated area of biopharma patent law

08 October 2019

An eyebrow-raising CJEU ruling could be bad news for generics

Europe’s highest court has handed down a surprising decision concerning the consequences of an “unjustified” preliminary injunction issued in a pharma patent case

01 October 2019

The top biopharma patent stories in September

Our round-up of all the major IP developments affecting the life sciences industries last month

28 September 2019

The US is gifting 5G patent leadership to others

Policy confusion and problematic court decisions mean that the shape of the IP landscape in this pivotal technology is being determined elsewhere

25 September 2019

Copyright clarification from Europe’s top court

Judges at the Court of Justice of the European Union delivered good news for designers in their Cofomel decision earlier this month

17 September 2019

Australia’s harsh approach to software patents set to continue

Observers had hoped Friday’s decision in the Encompass case would clarify key patentability questions. But a Full Bench of the Federal Court of Australia did not take the opportunity to do so

13 September 2019

Patent litigation is one reason why the UK will remain in the legal premier league

Despite the pervading sense of gloom, the quality of English courts and lawyers - and the remedies now available to plaintiffs - mean that there is an IP bright spot amidst the carnage of Brexit

11 September 2019

Software IP issues for universities have never been more complex, says tech commercialisation leader

In an exclusive interview with IAM, given in the run-up to Software IP 2019, the University of Chicago's George Chellapa describes the challenges of the fast-moving sector and how working with industry is crucial

11 September 2019

Five things to watch for from Japan’s new IP policy leadership

The new commissioner of the JPO and top cabinet advisor on IP will both address IPBC Asia in Tokyo in some of their first appearances in front of a global audience

07 September 2019

Life sciences IP - the major developments in August

All the big pharma and biotech patent stories from last month in our regular monthly round-up

28 August 2019

Asia's top IP owners revealed

Big filers, tough litigators and savvy dealmakers identified across eight industries in the run-up to IPBC Asia in Tokyo this October

24 August 2019

Adversaries no more - licensors look to make deals, not settlements

In its day, the IPNav model was hugely successful in generating cash, but successful licensing in the here and now requires a different, less confrontational approach

14 August 2019

USPTO Director Iancu set to keynote IAM’s patent litigation event as 101 legislation debate continues

American Express, Nokia, Google, Nasdaq, Volkswagen, Novartis and Merck executives among the final speakers revealed for prestigious November conference in Washington DC

10 August 2019

A No Deal Brexit now looks unavoidable, so plan accordingly

Boris Johnson becoming Prime Minister has totally changed the trajectory of the UK's departure from the EU and IP owners' strategies should reflect that

03 August 2019

Life sciences IP – the major developments in July

All the big pharma and biotech patent stories from last month in our regular monthly round-up